Dorsey Wright & Associates’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$59K Sell
2,824
-174
-6% -$3.26K 0.02% 123
2022
Q1
$65K Sell
2,998
-406
-12% -$8.81K 0.02% 150
2021
Q4
$94K Buy
3,404
+464
+16% +$11.2K 0.02% 145
2021
Q3
$62K Buy
2,940
+232
+9% +$4.35K 0.01% 167
2021
Q2
$45K Buy
+2,708
New +$41.3K 0.01% 219
2020
Q1
Sell
-1,050
Closed -$12K 280
2019
Q4
$12K Buy
+1,050
New +$11.9K ﹤0.01% 189

Other funds holding CCRN

Dorsey Wright & Associates's CCRN Position: Q2 2022 in Review

Dorsey Wright & Associates reduced its Cross Country Healthcare (CCRN) stake by 5.8% in Q2 2022, selling an estimated $3.26K and leaving 2,824 shares worth $59K. The position accounts for 0.02% of the portfolio, ranked #123.

Dorsey Wright & Associates first reported a position in CCRN in Q4 2019 and has held it in 6 quarters since. The position peaked at $94K in Q4 2021. 181 funds tracked by Wall St. Rank hold CCRN as of Q2 2022.

  • Dorsey Wright & Associates held 2,824 shares of Cross Country Healthcare worth $59K as of Q2 2022.
  • Dorsey Wright & Associates sold 174 Cross Country Healthcare shares in Q2 2022, an estimated $3.26K.
  • Cross Country Healthcare made up 0.02% of Dorsey Wright & Associates's portfolio in Q2 2022, its #123 holding.
  • Dorsey Wright & Associates first reported a position in Cross Country Healthcare in Q4 2019 and has held it in 6 quarters since.
  • Dorsey Wright & Associates's Cross Country Healthcare position peaked at $94K in Q4 2021.
  • 181 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2022.

Based on Dorsey Wright & Associates's 13F filing for Q2 2022, filed 20 Jul 2022.